EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparative analysis of gut microbiota in hormone‐sensitive and castration‐resistant prostate cancer in Japanese men

Saizo Fujimoto iD, Koji Hatano, Eri Banno, Daisuke Motooka, Marco Antonio De Velasco iD, Yurie Kura, Shingo Toyoda, Mamoru Hashimoto, Shogo Adomi, Takafumi Minami, Kazuhiro Yoshimura, Toshiki Oka und 11 weitere

Cancer Science · 2025-02 · 116 (2) · 462-469

DOI: 10.1111/cas.16408 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cancer Science, online erschienen am 03.12.2024. Verfasst von Saizo Fujimoto und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kindai University School of Medicine, Osaka-Sayama, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Yakult Bio-Science Foundation, The Japanese Foundation for Prostate Research (JFPR), The Japanese Urological Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota plays a crucial role in the development and progression of prostate cancer, with previous studies indicating that certain bacterial taxa are more abundant in castration‐resistant prostate cancer (CRPC) compared to hormone‐sensitive prostate cancer (HSPC). Notably, the composition of gut microbiota can vary significantly by geographic region, and Japanese individuals have a distinct microbial profile. However, research exploring these differences within Japanese populations remains limited. This study investigated the gut microbiota differences between Japanese men with HSPC and CRPC and further validated these findings using a transgenic mouse model. Rectal swab samples were collected from 140 Japanese men diagnosed with HSPC ( n = 84) or CRPC ( n = 56) between September 2020 and July 2022. Gut microbiota composition was analyzed using 16S rRNA gene sequencing. Additionally, Pten ‐KO mice, which model the progression from HSPC to CRPC, underwent similar microbiota analysis. Results revealed significant differences in gut microbiota composition between HSPC and CRPC patients. Specifically, the CRPC group showed a higher abundance of Firmicutes, including Gemella and Lactobacillus , compared to the HSPC group. These differences were mirrored in the mouse model, where CRPC mice also showed an increase in these bacteria. This study identifies distinct microbial differences between HSPC and CRPC in Japanese men, suggesting that Gemella and Lactobacillus may be associated with the progression to castration resistance in prostate cancer. These findings suggest that gut microbiota differences may be associated with prostate cancer progression. Further research is needed to explore the potential of targeting the microbiota as a therapeutic strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeProstatic Neoplasms, Castration-ResistantMaleAnimalsHumansMiceAgedJapanRNA, Ribosomal, 16SMiddle AgedMice, KnockoutPTEN PhosphohydrolaseProstatic NeoplasmsDisease Models, AnimalDisease ProgressionMice, TransgenicEast Asian People

Stichwörter der Autor:innen

GemellaLactobacillusRuminococcusCRPCHSPCJapanesegut microbiotaprostate cancer

Substanzen

RNA, Ribosomal, 16SPTEN Phosphohydrolase

Autor:innen und Institutionen

  • Department of Urology, Kindai University School of Medicine, Osaka-Sayama, Japan.
  • Department of Urology, Osaka University Graduate School of Medicine, Suita, Japan.
  • Department of Genome Biology, Kindai University School of Medicine, Osaka-Sayama, Japan.
  • Department of Urology, Fukushima Medical University, Fukushima, Japan.
  • Department of Urology, Osaka General Medical Center, Osaka, Japan.
  • Department of Urology, Osaka Police Hospital, Osaka, Japan.

ORCID-Profile: Saizo Fujimoto, Marco Antonio De Velasco, Wataru Obara, Hirotsugu Uemura, Norio Nonomura

Förderung

  • Yakult Bio-Science Foundation
  • The Japanese Foundation for Prostate Research (JFPR)
  • The Japanese Urological Association
  • Japanese Urological Association

Zitieren

APA

Fujimoto, S., Hatano, K., Banno, E., Motooka, D., De Velasco, M. A., Kura, Y., Toyoda, S., Hashimoto, M., Adomi, S., Minami, T., Yoshimura, K., Oka, T., Hata, J., Matsushita, M., Takao, T., Takada, S., Tsujimura, A., Kojima, Y., Obara, W., …, & Fujita, K. (2025). Comparative analysis of gut microbiota in hormone‐sensitive and castration‐resistant prostate cancer in Japanese men. Cancer Science, 116(2), 462-469. https://doi.org/10.1111/cas.16408

Vancouver

Fujimoto S, Hatano K, Banno E, Motooka D, De Velasco MA, Kura Y, et al. Comparative analysis of gut microbiota in hormone‐sensitive and castration‐resistant prostate cancer in Japanese men. Cancer Science. 2025;116(2):462-469. doi:10.1111/cas.16408

BibTeX
@article{Fujimoto2025,
  author = {Fujimoto, Saizo and Hatano, Koji and Banno, Eri and Motooka, Daisuke and De Velasco, Marco Antonio and Kura, Yurie and Toyoda, Shingo and Hashimoto, Mamoru and Adomi, Shogo and Minami, Takafumi and Yoshimura, Kazuhiro and Oka, Toshiki and Hata, Junya and Matsushita, Makoto and Takao, Tetsuya and Takada, Shingo and Tsujimura, Akira and Kojima, Yasuyuki and Obara, Wataru and Nakamura, Shota and Uemura, Hirotsugu and Nonomura, Norio and Fujita, Kazutoshi},
  title = {Comparative analysis of gut microbiota in hormone‐sensitive and castration‐resistant prostate cancer in Japanese men},
  journal = {Cancer Science},
  year = {2025},
  volume = {116},
  number = {2},
  pages = {462--469},
  doi = {10.1111/cas.16408}
}
Kostenlos starten →